Understanding & Mitigating Cronobacter Contamination: How An Infant Formula Manufacturer Saved $2 Million
An infant formula manufacturer recently confirmed C. sakazakii was present in the environment, raw materials, and in-process and finished product — but they had several unanswered questions:
- Is the same strain of C. sakazakii detected every time, or are new strains being introduced?
- Where are the strains coming from and how are they migrating through the factory?
- What do we know about the strains and how can we mitigate future issues?
Each time C. sakazakii was found, it cost the manufacturer almost a full week of halted production and over $2 million in lost sales, variable and fixed operational expenses, and root cause analysis cost. When standard mitigation practices did not resolve the issues, they turned to bioMérieux for help.
Fill out the short form below to download our one-page case study detailing how we helped answer each of these lingering questions and help our partner make better, data-driven decisions.
